WADA clarifies facts regarding UCI decision on Christopher Froome

WADA clarifies facts regarding UCI decision on Christopher Froome / World Anti-Doping Agency (WADA). - Monteal : WADA, 2018

On 2 July 2018, the World Anti-Doping Agency (WADA) announced that it would not be appealing the Union Cycliste Internationale’s (UCI’s) decision not to assert an Anti-Doping Rule Violation (ADRV) in the case involving British rider Christopher Froome.

WADA accepted that the analytical result of Mr. Froome’s sample from 7 September 2017 during the Vuelta a España, which identified the prohibited substance salbutamol at a concentration in excess of the decision limit of 1,200 ng/mL, did not constitute an Adverse Analytical Finding (AAF). The Agency’s decision not to appeal the ruling of the UCI, which was the results management authority with sole jurisdiction in this case, was taken on the basis of a full and careful review of all explanations and supporting evidence submitted by Mr. Froome in June 2018 (which the UCI shared with WADA), as well as thorough consultation with internal and external experts.

While WADA remains convinced that the UCI reached the right and fair outcome on this very complex case, the Agency wishes to clarify elements that have been subject to much speculation and misinformation.

Original document

Parameters

Date
11 July 2018
Original Source
World Anti-Doping Agency (WADA)
Country
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Team Sky
World Anti-Doping Agency (WADA)
Analytical aspects
Threshold for exogenous substances
Doping classes
S3. Beta-2 Agonists
Substances
Salbutamol
Medical terms
Legitimate Medical Treatment
Therapeutic Use Exemption (TUE)
Document category
Press release
Statement
Document type
Pdf file
Date generated
16 July 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin